Computational simulations at the molecular level are crucial for advancing drug delivery systems by providing insights into drug-receptor interactions, permeation across biological barriers, solubility, stability and conformational changes. Techniques such as molecular modeling, molecular docking studies, molecular dynamics (MD) simulations, quantum mechanics/molecular mechanics (QM/MM) simulations, and free energy calculations play key roles. Molecular modeling predicts structures, conformations, and properties essential for drug efficacy. Docking studies forecast interactions and binding affinities, guiding lead optimization and toxicity assessment. MD simulations reveal drug behavior, stability, and interactions patterns. QM/MM simulations accurately model active sites and chemical reactions. Free energy calculations predict binding affinities and thermodynamic properties, enhancing our understanding of drug receptor interactions. These techniques optimize drug design, pharmacokinetics, and pharmacodynamics and targeted drug delivery systems. Visualization and analysis tools help interpret complex interactions, facilitating effective therapeutic interventions. Computational simulations span development stages, from design to clinical trial simulations, providing a robust frame work for safer and more effective pharmaceuticals. In-silico model accelerate drug discovery, reduce animal testing, address ethical concerns, and improve development pipeline efficacy.